Audit 316542

FY End
2023-12-31
Total Expended
$63.64M
Findings
2
Programs
53
Organization: Corewell Health & Affiliates (MI)
Year: 2023 Accepted: 2024-08-02

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
480317 2023-001 Significant Deficiency - L
1056759 2023-001 Significant Deficiency - L

Programs

ALN Program Spent Major Findings
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $39.72M Yes 0
93.498 Provider Relief Fund $7.68M Yes 1
93.817 Hospital Preparedness Program (hpp) Ebola Preparedness and Response Activities $1.38M - 0
93.926 Healthy Start Initiative $1.14M - 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $415,754 - 0
93.914 Hiv Emergency Relief Project Grants $284,016 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $275,738 Yes 0
93.301 Small Rural Hospital Improvement Grant Program $235,245 - 0
93.778 Medical Assistance Program $214,885 - 0
93.310 Trans-Nih Research Support $196,193 Yes 0
93.788 Opioid Str $165,959 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $159,087 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $158,733 - 0
93.276 Drug-Free Communities Support Program Grants $125,000 - 0
93.307 Minority Health and Health Disparities Research $107,022 Yes 0
93.889 National Bioterrorism Hospital Preparedness Program $75,155 - 0
93.865 Child Health and Human Development Extramural Research $58,205 Yes 0
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $53,478 - 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $50,985 - 0
93.399 Cancer Control $47,220 Yes 0
93.395 Cancer Treatment Research $41,996 Yes 0
93.835 Planning Grant for Healthcare and Public Health Sector Cybersecurity Information Sharing $40,057 Yes 0
93.855 Allergy, Immunology and Transplantation Research $37,801 Yes 0
93.361 Nursing Research $35,388 Yes 0
12.420 Military Medical Research and Development $33,960 Yes 0
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $30,512 - 0
93.178 Nursing Workforce Diversity $26,427 - 0
93.994 Maternal and Child Health Services Block Grant to the States $25,125 - 0
93.217 Family Planning Services $23,244 - 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $22,733 - 0
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $22,425 - 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $20,306 - 0
93.837 Cardiovascular Diseases Research $19,703 Yes 0
93.113 Environmental Health $19,589 Yes 0
93.397 Cancer Centers Support Grants $17,322 Yes 0
93.092 Affordable Care Act (aca) Personal Responsibility Education Program $14,426 - 0
93.859 Biomedical Research and Research Training $12,284 Yes 0
93.991 Preventive Health and Health Services Block Grant $10,000 - 0
93.977 Preventive Health Services_sexually Transmitted Diseases Control Grants $9,684 - 0
93.866 Aging Research $9,451 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $9,250 Yes 0
93.213 Research and Training in Complementary and Integrative Health $7,134 Yes 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $6,078 - 0
93.839 Blood Diseases and Resources Research $4,579 Yes 0
93.393 Cancer Cause and Prevention Research $4,480 Yes 0
93.940 Hiv Prevention Activities Health Department Based $4,261 - 0
93.867 Vision Research $2,085 Yes 0
93.279 Drug Abuse and Addiction Research Programs $1,902 Yes 0
12.300 Basic and Applied Scientific Research $1,690 Yes 0
93.838 Lung Diseases Research $1,655 Yes 0
93.350 National Center for Advancing Translational Sciences $616 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $290 Yes 0
93.103 Food and Drug Administration Research $58 - 0

Contacts

Name Title Type
LDABZVFUKNS3 Giacomo Dechellis Auditee
2487984702 Maureen Wood Auditor
No contacts on file

Notes to SEFA

Title: COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (Assistance Listing No. 93.498) Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of Corewell Health and Subsidiaries (the System) and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: The system did not use the de minimis cost rate. The Schedule includes $7,678,128 received from the U.S. Department of Health and Human Services (HHS) between January 1, 2022 through December 31, 2022 under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution program of Assistance Listing No. 93.498. In accordance with the guidance from HHS, these amounts are presented as Period 5 and Period 6 in the HHS PRF Reporting Portal. Such amounts were recognized as other revenue in the System’s financial statements as shown in the Schedule in the year ended December 31, 2022. Due to the PRF reporting requirements, these amounts are not the total PRF received and/or recognized as other revenue in the years presented in the Schedule.The amount presented reconciles the PRF information reported to the Health Resources and Services Administration (HRSA) as follows: See the Notes to the SEFA for chart/table.
Title: Disaster Grants – Public Assistance (Presidentially Declared Disasters) For the Federal Emergency Management Agency (FEMA), (Assistance Listing No. 97.036) Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of Corewell Health and Subsidiaries (the System) and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: The system did not use the de minimis cost rate. The System incurred expenditures in fiscal years 2020, 2021 and 2022 related to four project worksheets; however, FEMA did not obligate the project worksheets until fiscal year 2023. As a result, all Assistance Listing Number 97.036 federal expenditures reported in the Schedule for the year ended December 31, 2023 were incurred in prior years.

Finding Details

Finding 2023-001 Identification of the federal program: Federal Agency: U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Assistance Listing: 93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (PRF) Pass-Through Grantor: Not applicable Pass-Through Award Number: Not applicable Pass-Through Award Period: 1/1/2020–12/31/2023 (Periods 5 and 6) Criteria or specific requirement (including statutory, regulatory or other citation): 2 CFR Section 200.303 of the Uniform Guidance states the following regarding internal control: “The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” The Provider Relief Programs: Provider Relief Fund and ARP Rural Payments Frequently Asked Questions states the following: “If a Reporting Entity has more lost revenues for a “Payment Received Period” than it received Provider Relief Fund and/or ARP Rural payments for the same period, can those lost revenues be carried forward and applied against payments received during later “Payment Received Periods” and included in the lost revenues reported during later reporting periods? (Modified 5/5/2023). Yes. Provider Relief Fund and/or ARP Rural payments may be applied to expenses and lost revenues according to the period of availability of funding. However, expenses and lost revenues may not be duplicated. Specifically, payments received may not be applied to the same expenses and lost revenues that Provider Relief Fund or ARP Rural payments received in prior payment periods already reimbursed. The Payment Received Periods described in the Post-Payment Notice of Reporting Requirements determine the period of availability of funding and when reports are due. The opportunity to apply Provider Relief Fund payments (excluding the Nursing Home Infection Control Distribution) and ARP Rural payments for lost revenues will be available up to June 30, 2023, the end of the quarter in which the COVID-19 Public Health Emergency ends.” Condition: The “Total Lost Revenues for the Period of Availability (January 1, 2020 to June 30, 2023)” line in the HRSA PRF portal for Spectrum Health System (the Parent), TIN 383382353, General Distribution HRSA PRF report in Reporting Period 5 was $108,697,843. The amount of lost revenues reported for Period 5 should have been $107,045,743. The difference represents a $1.6 million error as a result of improperly adjusting for targeted funds to determine the Parent’s lost revenues for period 5. Cause: Management’s internal controls over the review of input of lost revenues into the HRSA PRF portal were not sufficient to ensure the lost revenues recorded in the General Distribution portal “Total Lost Revenues for the Period of Availability (January 1, 2020 to June 30, 2023)” line were appropriate. Effect or potential effect: The lost revenues reported in the HRSA PRF portal were misstated. Questioned costs: None. Context: There were three HRSA PRF reports submitted for the year ended December 31, 2023. We tested all three reports. Per our inspection of our sample of the three Corewell Health West HRSA PRF portal submissions for reporting period 5, we identified in one report that the “Total Lost Revenues for the Period of Availability (January 1, 2020 to June 30, 2023) line” was overstated by $1.6 million. The total amount of lost revenue reported for Period 5 was $107,045,743. The System had sufficient lost revenues even with the reporting misstatement. Total expenses reported on the Schedule for PRF for the year ended December 31, 2023, are $7,678,128. Identification as a repeat finding, if applicable: Not a repeat finding. Recommendation: We recommend that if PRF funding were received in future periods, management should implement more robust internal controls for review of the lost revenue input into the HRSA PRF Portal. Views of responsible officials: No further lost revenue reporting is required on the HRSA PRF Portal. Management will implement more robust internal controls in preparation for similar future filings.
Finding 2023-001 Identification of the federal program: Federal Agency: U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Assistance Listing: 93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (PRF) Pass-Through Grantor: Not applicable Pass-Through Award Number: Not applicable Pass-Through Award Period: 1/1/2020–12/31/2023 (Periods 5 and 6) Criteria or specific requirement (including statutory, regulatory or other citation): 2 CFR Section 200.303 of the Uniform Guidance states the following regarding internal control: “The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” The Provider Relief Programs: Provider Relief Fund and ARP Rural Payments Frequently Asked Questions states the following: “If a Reporting Entity has more lost revenues for a “Payment Received Period” than it received Provider Relief Fund and/or ARP Rural payments for the same period, can those lost revenues be carried forward and applied against payments received during later “Payment Received Periods” and included in the lost revenues reported during later reporting periods? (Modified 5/5/2023). Yes. Provider Relief Fund and/or ARP Rural payments may be applied to expenses and lost revenues according to the period of availability of funding. However, expenses and lost revenues may not be duplicated. Specifically, payments received may not be applied to the same expenses and lost revenues that Provider Relief Fund or ARP Rural payments received in prior payment periods already reimbursed. The Payment Received Periods described in the Post-Payment Notice of Reporting Requirements determine the period of availability of funding and when reports are due. The opportunity to apply Provider Relief Fund payments (excluding the Nursing Home Infection Control Distribution) and ARP Rural payments for lost revenues will be available up to June 30, 2023, the end of the quarter in which the COVID-19 Public Health Emergency ends.” Condition: The “Total Lost Revenues for the Period of Availability (January 1, 2020 to June 30, 2023)” line in the HRSA PRF portal for Spectrum Health System (the Parent), TIN 383382353, General Distribution HRSA PRF report in Reporting Period 5 was $108,697,843. The amount of lost revenues reported for Period 5 should have been $107,045,743. The difference represents a $1.6 million error as a result of improperly adjusting for targeted funds to determine the Parent’s lost revenues for period 5. Cause: Management’s internal controls over the review of input of lost revenues into the HRSA PRF portal were not sufficient to ensure the lost revenues recorded in the General Distribution portal “Total Lost Revenues for the Period of Availability (January 1, 2020 to June 30, 2023)” line were appropriate. Effect or potential effect: The lost revenues reported in the HRSA PRF portal were misstated. Questioned costs: None. Context: There were three HRSA PRF reports submitted for the year ended December 31, 2023. We tested all three reports. Per our inspection of our sample of the three Corewell Health West HRSA PRF portal submissions for reporting period 5, we identified in one report that the “Total Lost Revenues for the Period of Availability (January 1, 2020 to June 30, 2023) line” was overstated by $1.6 million. The total amount of lost revenue reported for Period 5 was $107,045,743. The System had sufficient lost revenues even with the reporting misstatement. Total expenses reported on the Schedule for PRF for the year ended December 31, 2023, are $7,678,128. Identification as a repeat finding, if applicable: Not a repeat finding. Recommendation: We recommend that if PRF funding were received in future periods, management should implement more robust internal controls for review of the lost revenue input into the HRSA PRF Portal. Views of responsible officials: No further lost revenue reporting is required on the HRSA PRF Portal. Management will implement more robust internal controls in preparation for similar future filings.